LiveDesign Reviews

Stop letting RFPs, audits, and compliance questionnaires become a costly administrative burden that ties up your best experts. Optivalue.ai is designed to turn this process from a chore into a competitive advantage. Our intelligent platform automates information discovery and response drafting, slashing response times by up to 90%. This frees your most qualified team members to focus on the high-impact personalization that wins bids and ensures compliance. Optivalue.ai acts as an expert librarian for your entire knowledge base. It securely connects to your systems, reading and understanding every document to know precisely where the best information is. Submit any questionnaire and receive a complete, source-verified draft in minutes. But we go beyond simple automation to deliver proven answers. For perfect traceability and absolute confidence, every statement is backed by a precise citation—source document, page, and date. You don’t just answer correctly; you prove it. Furthermore, Optivalue.ai is your engine for organizational progress. It performs a proactive gap analysis—a true "pre-flight check" on your documentation—to identify weaknesses and inconsistencies before your clients or auditors do. The platform provides actionable recommendations that continuously build your team's expertise. By following these suggestions to update your internal documents, you drive lasting, measurable progress across your entire organization. Manage your data with total peace of mind. Optivalue.ai is built with enterprise-grade security, fully compliant with strict standards like GDPR, HIPAA, ISO, and FedRAMP. To simplify your decision and make your costs predictable, we’ve included a key advantage in all our plans: unlimited users and projects. Scale your operations without worrying about complex tiers or surprise fees. Start your 14-day free trial today. No credit card required. No commitment.

Revaly is built to solve one of the most costly and overlooked problems in subscription commerce: legitimate payments failing for preventable reasons. Its end-to-end Payment Performance Management platform leverages machine learning, issuer intelligence, and ecosystem data to elevate approval rates starting from the very first transaction attempt. The system automatically detects issues such as mistyped card numbers, routing mismatches, and metadata errors before a customer ever checks out. When payments do fail, Revaly uses a sophisticated retry engine that studies customer behavior, card network patterns, and historical success windows to recover revenue without damaging relationships. Businesses across industries report dramatic improvements—from 34% to over 50% increases in recovered payments—demonstrating the compound value of consistent, optimized approvals. Revaly’s integration ecosystem makes adoption frictionless, connecting seamlessly with CRMs, billing systems, payment gateways, and processors already in use. The platform not only protects revenue but stabilizes growth by reducing churn that comes from unintentional payment failures. Leadership teams gain visibility into payment performance metrics that go far beyond authorization rates, revealing hidden revenue opportunities and operational inefficiencies. As a result, companies can build smarter billing strategies and deliver a more reliable experience for customers. Revaly becomes a trusted partner in improving profitability, ensuring that when a customer says “yes,” the payment system does too.

Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.